906 related articles for article (PubMed ID: 30894142)
1. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
[TBL] [Abstract][Full Text] [Related]
2. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
[TBL] [Abstract][Full Text] [Related]
3. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
Sakae N; Josephs KA; Litvan I; Murray ME; Duara R; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
Mov Disord; 2019 Nov; 34(11):1655-1662. PubMed ID: 31433871
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
Ling H; de Silva R; Massey LA; Courtney R; Hondhamuni G; Bajaj N; Lowe J; Holton JL; Lees A; Revesz T
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):149-63. PubMed ID: 23432126
[TBL] [Abstract][Full Text] [Related]
5. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
Jellinger KA
Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
[TBL] [Abstract][Full Text] [Related]
6. Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.
Schofield EC; Hodges JR; Macdonald V; Cordato NJ; Kril JJ; Halliday GM
Mov Disord; 2011 Feb; 26(2):256-63. PubMed ID: 21412832
[TBL] [Abstract][Full Text] [Related]
7. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T; Tolosa E; Ferrer I
Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
[TBL] [Abstract][Full Text] [Related]
8. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
Picillo M; Cuoco S; Tepedino MF; Cappiello A; Volpe G; Erro R; Santangelo G; Pellecchia MT; Barone P;
J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
[TBL] [Abstract][Full Text] [Related]
9. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy.
Williams DR; Holton JL; Strand K; Revesz T; Lees AJ
Mov Disord; 2007 Nov; 22(15):2235-41. PubMed ID: 17712855
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
[TBL] [Abstract][Full Text] [Related]
11. Does corticobasal degeneration exist? A clinicopathological re-evaluation.
Ling H; O'Sullivan SS; Holton JL; Revesz T; Massey LA; Williams DR; Paviour DC; Lees AJ
Brain; 2010 Jul; 133(Pt 7):2045-57. PubMed ID: 20584946
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features of progressive supranuclear palsy with asymmetrical atrophy of the superior cerebellar peduncle.
Koizumi R; Akagi A; Riku Y; Sone J; Miyahara H; Tanaka F; Yoshida M; Iwasaki Y
Neuropathology; 2023 Jun; 43(3):233-243. PubMed ID: 36222051
[TBL] [Abstract][Full Text] [Related]
13. Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [
Schönecker S; Palleis C; Franzmeier N; Katzdobler S; Ferschmann C; Schuster S; Finze A; Scheifele M; Prix C; Fietzek U; Weidinger E; Nübling G; Vöglein J; Patt M; Barthel H; Sabri O; Danek A; Höglinger GU; Brendel M; Levin J;
Neuroimage Clin; 2023; 38():103402. PubMed ID: 37087820
[TBL] [Abstract][Full Text] [Related]
14. [Progressive supranuclear palsy; an unusual form of parkinsonism].
Donker Kaat L; Boon AJ; Heutink P; van Swieten JC
Ned Tijdschr Geneeskd; 2004 Mar; 148(11):519-23. PubMed ID: 15054950
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
[TBL] [Abstract][Full Text] [Related]
16. Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series.
Yoshida K; Hata Y; Kinoshita K; Takashima S; Tanaka K; Nishida N
Acta Neuropathol; 2017 May; 133(5):809-823. PubMed ID: 28064358
[TBL] [Abstract][Full Text] [Related]
17. Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy.
Tanaka H; Martinez-Valbuena I; Forrest SL; Couto B; Reyes NG; Morales-Rivero A; Lee S; Li J; Karakani AM; Tang-Wai DF; Tator C; Khadadadi M; Sadia N; Tartaglia MC; Lang AE; Kovacs GG
Brain; 2024 Apr; 147(4):1399-1411. PubMed ID: 37972275
[TBL] [Abstract][Full Text] [Related]
18. Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants.
Orlandi F; Carlos AF; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Stephens YC; Schwarz CG; Senjem ML; Jack CR; Agosta F; Filippi M; Dickson DW; Josephs KA; Whitwell JL
Brain Commun; 2024; 6(2):fcae113. PubMed ID: 38660629
[TBL] [Abstract][Full Text] [Related]
19. Progressive supranuclear palsy.
Giagkou N; Höglinger GU; Stamelou M
Int Rev Neurobiol; 2019; 149():49-86. PubMed ID: 31779824
[TBL] [Abstract][Full Text] [Related]
20. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia.
Josephs KA; Boeve BF; Duffy JR; Smith GE; Knopman DS; Parisi JE; Petersen RC; Dickson DW
Neurocase; 2005 Aug; 11(4):283-96. PubMed ID: 16093229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
